NASDAQ
ABSI

Absci Corp

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

Absci Corp Stock Price

Vitals

Today's Low:
$1.6
Today's High:
$1.68
Open Price:
$1.66
52W Low:
$1.94
52W High:
$9.38
Prev. Close:
$1.66
Volume:
234101

Company Statistics

Market Cap.:
$197.73 million
Book Value:
3.154
Revenue TTM:
$5.64 million
Operating Margin TTM:
-1983.57%
Gross Profit TTM:
$-39804000
Profit Margin:
0%
Return on Assets TTM:
-17.74%
Return on Equity TTM:
-32.48%

Company Profile

Absci Corp had its IPO on 2021-07-22 under the ticker symbol ABSI.

The company operates in the Healthcare sector and Biotechnology industry. Absci Corp has a staff strength of 211 employees.

Stock update

Shares of Absci Corp opened at $1.66 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.6 - $1.68, and closed at $1.61.

This is a -3.01% slip from the previous day's closing price.

A total volume of 234,101 shares were traded at the close of the day’s session.

In the last one week, shares of Absci Corp have slipped by -13.9%.

Absci Corp's Key Ratios

Absci Corp has a market cap of $197.73 million, indicating a price to book ratio of 0.8264 and a price to sales ratio of 42.7421.

In the last 12-months Absci Corp’s revenue was $5.64 million with a gross profit of $-39804000 and an EBITDA of $-99703000. The EBITDA ratio measures Absci Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Absci Corp’s operating margin was -1983.57% while its return on assets stood at -17.74% with a return of equity of -32.48%.

In Q3, Absci Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 53.9%.

Absci Corp’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-0.85 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Absci Corp’s profitability.

Absci Corp stock is trading at a EV to sales ratio of 14.6935 and a EV to EBITDA ratio of -0.8411. Its price to sales ratio in the trailing 12-months stood at 42.7421.

Absci Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$339.39 million
Total Liabilities
$30.03 million
Operating Cash Flow
$-78723000.00
Capital Expenditure
$4.87 million
Dividend Payout Ratio
0%

Absci Corp ended 2024 with $339.39 million in total assets and $0 in total liabilities. Its intangible assets were valued at $339.39 million while shareholder equity stood at $292.94 million.

Absci Corp ended 2024 with $756000.00 in deferred long-term liabilities, $30.03 million in other current liabilities, 9000.00 in common stock, $-276458000.00 in retained earnings and $21.34 million in goodwill. Its cash balance stood at $107.32 million and cash and short-term investments were $181.31 million. The company’s total short-term debt was $6,510,000 while long-term debt stood at $6.52 million.

Absci Corp’s total current assets stands at $201.38 million while long-term investments were $0 and short-term investments were $73.99 million. Its net receivables were $210000.00 compared to accounts payable of $1.86 million and inventory worth $0.

In 2024, Absci Corp's operating cash flow was $-78723000.00 while its capital expenditure stood at $4.87 million.

Comparatively, Absci Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$1.61
52-Week High
$9.38
52-Week Low
$1.94
Analyst Target Price
$12

Absci Corp stock is currently trading at $1.61 per share. It touched a 52-week high of $9.38 and a 52-week low of $9.38. Analysts tracking the stock have a 12-month average target price of $12.

Its 50-day moving average was $1.82 and 200-day moving average was $2.02 The short ratio stood at 7.35 indicating a short percent outstanding of 0%.

Around 3198.9% of the company’s stock are held by insiders while 4478.9% are held by institutions.

Frequently Asked Questions About Absci Corp

The stock symbol (also called stock or share ticker) of Absci Corp is ABSI

The IPO of Absci Corp took place on 2021-07-22

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
$396.65
-3.2
-0.8%
$9.06
-0.18
-1.95%
$306.9
8.05
+2.69%
KDDL LTD.-$ (KDDL*)
$1808
-66.1
-3.53%
Hubtown Limited (532799)
$52.04
-0.32
-0.61%
$58.1
-0.65
-1.11%
$0.5
-0.03
-6.35%
$7.72
-0.17
-2.15%
$3.65
0.09
+2.53%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Address

18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683